These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7607408)

  • 21. Meropenem resistance in Pseudomonas aeruginosa.
    Sumita Y; Fukasawa M
    Chemotherapy; 1996; 42(1):47-56. PubMed ID: 8751266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
    Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
    Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
    Van der Auwera P; Husson M; Bulliard G
    Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL; Fang YP
    Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
    Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
    Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
    Livermore DM; Williams JD; Davy KW
    Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Pragsam AK; Kumar DT; Doss CGP; Iyadurai R; Satyendra S; Rodrigues C; Joshi S; Roy I; Chaudhuri BN; Chitnis DS; Tapan D; Veeraraghavan B
    Indian J Med Microbiol; 2018; 36(1):127-130. PubMed ID: 29735843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model.
    Karadenizli A; Mutlu B; Okay E; Kolayli F; Vahaboglu H
    Chemotherapy; 2001; 47(4):292-6. PubMed ID: 11399866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
    Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth temperature regulates the induction of beta-lactamase in Pseudomonas fluorescens through modulation of the outer membrane permeation of a beta-lactam-inducing antibiotic.
    Orange N
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():3125-30. PubMed ID: 7812451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus on β-Lactamase Nomenclature.
    Bradford PA; Bonomo RA; Bush K; Carattoli A; Feldgarden M; Haft DH; Ishii Y; Jacoby GA; Klimke W; Palzkill T; Poirel L; Rossolini GM; Tamma PD; Arias CA
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0033322. PubMed ID: 35380458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small diffusion pore in the outer membrane of Pseudomonas aeruginosa.
    Yoneyama H; Nakae T
    Eur J Biochem; 1986 May; 157(1):33-8. PubMed ID: 3086091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of L-2 type beta-lactamases from Stenotrophomonas maltophilia to serine active site beta-lactamase inhibitors.
    Pradhananga SL; Rowling PJ; Simpson IN; Payne DJ
    J Antimicrob Chemother; 1996 Feb; 37(2):394-6. PubMed ID: 8707755
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-frequency ultrasound increases outer membrane permeability of Pseudomonas aeruginosa.
    Runyan CM; Carmen JC; Beckstead BL; Nelson JL; Robison RA; Pitt WG
    J Gen Appl Microbiol; 2006 Oct; 52(5):295-301. PubMed ID: 17310073
    [No Abstract]   [Full Text] [Related]  

  • 38. A rapid and simple method for detection of beta-lactamase inhibitors.
    Uri JV; Actor P; Weisbach JA
    J Antibiot (Tokyo); 1978 Aug; 31(8):789-91. PubMed ID: 308500
    [No Abstract]   [Full Text] [Related]  

  • 39. Private benefit of β-lactamase dictates selection dynamics of combination antibiotic treatment.
    Ma HR; Xu HZ; Kim K; Anderson DJ; You L
    Nat Commun; 2024 Sep; 15(1):8337. PubMed ID: 39333122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.
    Li XZ; Zhang L; Srikumar R; Poole K
    Antimicrob Agents Chemother; 1998 Feb; 42(2):399-403. PubMed ID: 9527793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.